Day: January 10, 2024

This notice is published with reference to the initial public offering of the shares of AS Infortar (“Infortar”) and should be read in conjunction with Infortar’s public offering, listing and admission to trading prospectus dated 24 November 2023 (the “Prospectus”), together with Infortar’s notification on the results of the initial public offering of its shares and final price dated 11 December 2023. Infortar informs that on period commencing on 04 January 2024 and ending on 10 January 2024 (both included) the following stabilisation measures on following conditions were carried out by Swedbank AS as the Stabilising Arranger: Company: AS InfortarSecurities: INFORTAR LIHTAKTSIA, ISIN code: EE3100149394Ticker: INF1TStabilising Arranger: Swedbank ASTrading Venue: Nasdaq Tallinn Stock ExchangeStabilisation Period Start...

Miami Beach, Fla., Jan. 10, 2024 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) is thrilled to announce a collaboration that’s sure to electrify El Salvador. Teaming up with Grupo Q, Porsche’s official dealer throughout El Salvador, the Company will be launching five advanced EV charging stations in select premium retail and restaurant locations in the Santa Tecla, Costa del Sol, Santa Ana, San Miguel, and Playa La Libertad regions. The launch of Blink’s chargers is part of Porsche’s Destination Charging Program – Porsche’s global initiative to expand and ensure EV charging infrastructure worldwide. These chargers are strategically placed at high-demand locations like hotels, restaurants, golf clubs, retail shops, and marinas. In El Salvador, the select Blink chargers will be publicly accessible to all EV drivers in the region,...

First enrollment and first subject dosing expected soon at Erasmus Medical Center in Rotterdam, Netherlands Management discusses the announcement and what this means here: video OCALA, Fla., Jan. 10, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that enrollment is open at Erasmus Medical Center (“Erasmus MC”) in a Phase 1b/2 clinical trial combining AIM’s Ampligen® (rintatolimod) with AstraZeneca’s anti-PD-L1 immune checkpoint inhibitor Imfinzi® (durvalumab) for the treatment of pancreatic cancer (the “DURIPANC Study”). Ampligen has shown therapeutic synergies with checkpoint inhibitors, potentially increasing survival rates and efficacy. AIM announced in January 2023 that it had entered into an external sponsored collaborative clinical research agreement with Erasmus...

Drilling At Jean Lake to Commence in February to Expand the Confirmed Lithium and Gold MineralizationFig. 1Map Highlighting B-1, and B-2 in Proximity to Other Trends and Deposits in the AreaFig. 2Planned Drillholes for 2024 Jean Lake Property Drill ProgramVANCOUVER, British Columbia, Jan. 10, 2024 (GLOBE NEWSWIRE) — Foremost Lithium Resource & Technology Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost Lithium”, “Foremost” or the “Company”), a North American hard-rock lithium exploration company, is pleased to confirm today that it received a multi-year work permit for its Jean Lake Lithium/Gold Project from the Mining Permit Office of the Manitoba Government, valid until April 30th of 2026. This permit will enable the Company to streamline the administrative processes involved with future exploration on the property,...

This backlog includes only purchase orders the Company has already received and does not include other work the Company receives daily SAN ANTONIO, Texas, Jan. 10, 2024 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a developer and marketer of glass strengthening solutions for enhanced safety, announced today its Patriot Glass Solutions subsidiary has a backlog in excess of $3.3 million heading into 2024. This backlog includes purchase orders the Company has already received and announced but has not yet started the installations for and does not include other work Patriot Glass Solutions does on a daily basis. The Company expects the majority of this backlog to be installed in 2024, but a portion of it could stretch into 2025 since some projects are new construction, etc. These projects primarily include...

BEIJING, Jan. 10, 2024 (GLOBE NEWSWIRE) — Secoo Holding Limited (“Secoo” or the “Company”) (NASDAQ: SECO) today announced that on January 5, 2024, it received an additional delinquency letter from The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that (i) the Company is not in compliance with Nasdaq’s continued listing requirements set forth in Nasdaq Listing Rule 5250(c)(1) due to the Company’s failure to file its Form 6-K containing an interim balance sheet and income statement as of the end of its second quarter ended June 30, 2023, which serves as an additional basis for delisting the Company’s securities from Nasdaq, and (ii) the Nasdaq Hearings Panel (the “Panel”) will consider this matter in rendering a determination regarding the Company’s continued listing on Nasdaq. The Nasdaq additional delinquency letter...